Investors pony up $476M for the latest round of biotech IPOs to hit the Street
Three biotechs — and a genome sequencing player — have caught the latest tide to the Gold Coast of IPOs, rounding out the first half of 2019 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
